Hikma Injectables USA Inc recalls phenylephrine in 0.9% Sodium Chloride Inj
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
- Products
-
- phenylephrine in 0.9% Sodium Chloride Inj
- Company
- Hikma Injectables USA Inc
- Where it was sold
-
Nationwide in the USA
Nationwide
- About this recall
- phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25